Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

The Indian pharmaceutical industry: a time of growth and cha...

In the first of a two-part interview we speak with Tapan Ray on the changing regulatory environment in India and how it is shaping the industry there. The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to...

Articles

Compliance trends in Europe

Rebecca Aris highlights the findings from the latest European compliance trends report by Cegedim Relationship Management. Just how well equipped is pharma to deal with transparency regulations? European pharma is being transformed by transparency regulations. In the UK, the UK Bribery Act and FCPA are shaping our...

Articles

mHealth Monthly Mashup: Release 8.0 – how to get the most ou...

Excitedly looking into 2012, Michael Spitz interviews Brian Edwards, Senior mHealth Analyst, reviewer, and project manager. This is the first of the two part interview. Senior mHealth Analyst Brian T. Edwards (@healthgrid) brings a unique industry-based perspective to iMedicalApps.com…

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.